mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.9 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |